Bradycardia in a pediatric population after sugammadex administration: case series

AUTOR(ES)

Carvalho, Erica Viviana Guimarães; Caldas, Sandra Maria Carvalho; Costa, Dinis Fernando Pereira Pinheiro Machado da; Gomes, Cristina Maria Graça Peixoto

FONTE

Brazilian Journal of Anesthesiology

DATA DE PUBLICAÇÃO

2023

RESUMO

Abstract Sugammadex is a distinctive neuromuscular reversal drug that acts by encapsulating the neuromuscular relaxant molecule and dislodging it from its site of action. Sugammadex has been approved for pediatric patients over 2 years of age. Although arrhythmias have been reported, there is no report of adverse effects in healthy children, such as severe bradycardia requiring intervention. We report two cases of severe bradycardia immediately after the administration of sugammadex in healthy children. Our aim is to alert to the occurrence of one of the most severe adverse effects of sugammadex, in the healthy pediatric population as well.

Documentos Relacionados

• Sugammadex administration in pregnant patients undergoing non-obstetric surgery: a case series
• Severe bradycardia and asystole associated with sugammadex: case report
• Personnel Administration: The Case Method of Teaching *
• Case study in public administration: a critical review of Brazilian scientific production
• Growth retardation after dexamethasone administration: assessment by knemometry.